As for PES, Li et al. [29] demonstrated that depletion of PES1 suppressed cell proliferation and attenuated tumorigenicity in breast cancer, suggesting that PES1 could work as a marker for the breast cancer therapy. The gene discussed is PES1; the disease is breast carcinoma.